Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2433-2437, May 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McHugh, R. S.
Right arrow Articles by Selvaraj, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McHugh, R. S.
Right arrow Articles by Selvaraj, P.
[Cancer Research 59, 2433-2437, May 15, 1999]
© 1999 American Association for Cancer Research


Immunology

Protein Transfer of Glycosyl-phosphatidylinositol-B7-1 into Tumor Cell Membranes

A Novel Approach to Tumor Immunotherapy1

Rebecca S. McHugh, Shanmugam Nagarajan, Yi-Chong Wang, Kenneth W. Sell and Periasamy Selvaraj2

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322

Modification of tumor cells with one or more costimulatory adhesion molecules has been proposed as a means to develop therapeutic cancer vaccines for use in human immunotherapy. Expression of B7-1 (CD80) in tumors by gene transfer creates an immunogenic tumor cell that induces antitumor immunity and protects mice from further challenge with wild-type tumor cells. In this report, we demonstrate that protein transfer of glycosyl-phosphatidylinositol (GPI)-anchored costimulatory molecules into tumor cell membranes could be used as an alternative to gene transfer for tumor immunotherapy. Incubation of isolated tumor membranes with purified GPI-anchored B7-1 results in stable incorporation of B7-1 on tumor cell membranes within a few hours. Immunization of C57BL/6 mice with EG7 tumor membranes modified to express GPI-B7-1 by protein transfer induces tumor-specific T-cell proliferation and CTLs. In addition, immunization with these EG7 membranes protects mice from parental tumor challenge. The protein transfer approach used here does not require foreign vectors or live tumor cells and is completed within a matter of hours. Irradiated cells or membrane preparations from fresh or frozen tumor tissue can be used. Therefore, protein transfer of glycolipid-anchored molecules provides an efficient and novel approach to modify tumor membranes for human immunotherapy. This approach is not limited to costimulatory molecules because any cell surface protein can be converted to a GPI-anchored form by recombinant techniques.




This article has been cited by other articles:


Home page
BMJHome page
G. A Poland, D. Murray, and R. Bonilla-Guerrero
Science, medicine, and the future: New vaccine development
BMJ, June 1, 2002; 324(7349): 1315 - 1319.
[Full Text] [PDF]


Home page
Protein Eng Des SelHome page
A. Chenal, P. Nizard, V. Forge, M. Pugniere, M.-O. Roy, J.-C. Mani, F. Guillain, and D. Gillet
Does fusion of domains from unrelated proteins affect their folding pathways and the structural changes involved in their function? A case study with the diphtheria toxin T domain
Protein Eng. Des. Sel., May 1, 2002; 15(5): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nagarajan and P. Selvaraj
Glycolipid-anchored IL-12 Expressed on Tumor Cell Surface Induces Antitumor Immune Response
Cancer Res., May 1, 2002; 62(10): 2869 - 2874.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Zheng, A. Chen, R. E. Sterner, P. J. Zhang, T. Pan, N. Kiyatkin, and M. L. Tykocinski
Induction of Antitumor Immunity via Intratumoral Tetra-Costimulator Protein Transfer
Cancer Res., November 1, 2001; 61(22): 8127 - 8134.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
P. Nizard, A. Chenal, B. Beaumelle, A. Fourcade, and D. Gillet
Prolonged display or rapid internalization of the IgG-binding protein ZZ anchored to the surface of cells using the diphtheria toxin T domain
Protein Eng. Des. Sel., June 1, 2001; 14(6): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. Christ, S. Matzku, C. Burger, and M. Zöller
Interleukin 2-Antibody and Tumor Necrosis Factor-Antibody Fusion Proteins Induce Different Antitumor Immune Responses in Vivo
Clin. Cancer Res., May 1, 2001; 7(5): 1385 - 1397.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
S. K. Yoshinaga, M. Zhang, J. Pistillo, T. Horan, S. D. Khare, K. Miner, M. Sonnenberg, T. Boone, D. Brankow, T. Dai, et al.
Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS
Int. Immunol., October 1, 2000; 12(10): 1439 - 1447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chen, G. Zheng, and M. L. Tykocinski
Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method
J. Immunol., January 15, 2000; 164(2): 705 - 711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.